ArticleCureus2026
Beyond the Usual Suspects: Cytomegalovirus-Driven Hemophagocytic Lymphohistiocytosis (HLH) in a Previously Healthy Adult.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a potentially life-threatening syndrome characterized by excessive immune activation and cytokine storm. While primary HLH is genetic and typically presents in childhood, secondary HLH is acquired and often triggered by malignancy, autoimmune disorders, or infections. Acute cytomegalovirus (CMV) infection is a known trigger, although it is rarely the primary cause in immunocompetent adults. We present the case of a healthy 33-year-old female presenting with three weeks of high-grade fever and flank pain following treatment for a presumed urinary tract infection. Despite multiple courses of antibiotics, her symptoms persisted. Evaluation revealed hepatitis, cytopenias, and splenomegaly. Testing confirmed acute CMV infection with a relatively low viral titer. However, the patient met the diagnostic criteria for HLH with a high H-score. She was successfully treated with antivirals, corticosteroids, and intravenous immunoglobulin (IVIG). This case highlights the necessity of considering HLH in the differential diagnosis of fever of unknown origin (FUO) and underscores that even mild CMV viremia can precipitate life-threatening HLH in immunocompetent adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.